FENC news

Latest 1 stories · newest May 22, 2026

FENC

Fennec Pharmaceuticals presents new PEDMARK research at 2026 ASCO meeting

Fennec announced four independent studies evaluating PEDMARK (sodium thiosulfate) across multiple patient populations at ASCO 2026, expanding evidence for broader use beyond pediatric patients. The research demonstrates potential to reduce cisplatin-induced hearing loss in adolescent, young adult, a…

Regulatory May 22, 2026 sentiment +0.75 SEC filing ↗

BriefTape provides AI-summarized public SEC filings for informational purposes only. Content does not constitute investment advice. Always verify against source filings at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.

The same FENC feed as JSON for your bot or app:

GET https://api.brieftape.com/v1/tickers/FENC/newsSTART FREE